4.7 Article

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

期刊

RADIOTHERAPY AND ONCOLOGY
卷 154, 期 -, 页码 327-353

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2020.11.018

关键词

Endometrial carcinoma; Guidelines; Staging; Molecular markers; Management

资金

  1. ESGO fund
  2. ESTRO fund
  3. ESP fund

向作者/读者索取更多资源

The European consensus conference in 2014 produced evidence-based multidisciplinary guidelines for the management of endometrial carcinoma, aiming to improve the quality of care for women with the disease across Europe and worldwide. An international multidisciplinary development group reviewed literature published since 2014 to update the guidelines, which cover various aspects of endometrial carcinoma care based on the best available evidence and expert consensus.
A European consensus conference on endometrial carcinoma was held in 2014 to produce multidisciplinary evidence-based guidelines on selected questions. Given the large body of literature on the management of endometrial carcinoma published since 2014, the European Society of Gynaecological Oncology (ESGO), the European SocieTy for Radiotherapy & Oncology (ESTRO) and the European Society of Pathology (ESP) jointly decided to update these evidence-based guidelines and to cover new topics in order to improve the quality of care for women with endometrial carcinoma across Europe and worldwide. ESGO/ESTRO/ESP nominated an international multidisciplinary development group consisting of practicing clinicians and researchers who have demonstrated leadership and expertise in the care and research of endometrial carcinoma (27 experts across Europe). To ensure that the guidelines are evidence-based, the literature published since 2014, identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group. The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 191 independent international practitioners in cancer care delivery and patient representatives. The guidelines comprehensively cover endometrial carcinoma staging, definition of prognostic risk groups integrating molecular markers, pre- and intra-operative work-up, fertility preservation, management for early, advanced, metastatic, and recurrent disease and palliative treatment. Principles of radiotherapy and pathological evaluation are also defined. (C) 2021, Elsevier B.V.; International Gynecologic Cancer Society and European Society of Gynecological Oncology; Springer Verlag GmbH Berlin Heidelberg, part of Springer Nature. All rights reserved. Radiotherapy and Oncology

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据